Clinical evaluation of zaleplon in the treatment of insomnia
Authors:
Open Access
- 1 July 2010
- journal article
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. 2, 115-26
Abstract
Peer reviewed article authored by (Marieke M Ebbens, Joris C Verster). Read article or submit your manuscript for publishing.Keywords
This publication has 61 references indexed in Scilit:
- International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. UpdatePharmacological Reviews, 2008
- Comparison of Zolpidem and Zaleplon Exposures in Texas, 1998–2004Journal of Toxicology and Environmental Health, Part A, 2006
- Postural Instability and Consequent Falls and Hip Fractures Associated with Use of Hypnotics in the ElderlyDrugs & Aging, 2005
- Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakeningHuman Psychopharmacology: Clinical and Experimental, 2001
- ZaleplonDrugs, 2000
- A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakeningBritish Journal of Clinical Pharmacology, 1999
- Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound EffectsThe Primary Care Companion For CNS Disorders, 1999
- Efficacy of L‐846 in patients with insomnia:Evaluation by polysomnographyPsychiatry and Clinical Neurosciences, 1998
- Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoformsXenobiotica, 1998
- A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine HypnoticThe Journal of Clinical Pharmacology, 1994